North Potomac, MD, United States of America

Arun K Sarkar

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 3.9

ph-index = 10

Forward Citations = 250(Granted Patents)


Location History:

  • Birmingham, AL (US) (1997)
  • North Potomac, MD (US) (2009 - 2024)

Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: **Arun K Sarkar: Innovator in E-Selectin Antagonism**

Introduction

Arun K Sarkar is a distinguished inventor based in North Potomac, MD, with a remarkable portfolio of 21 patents. His innovations primarily focus on E-selectin antagonists, which are critical for the treatment and prevention of various cancers and other diseases. Sarkar's contributions to the field of biochemistry and medicine demonstrate the crucial intersection of research and practical application.

Latest Patents

Among his latest patents, Sarkar has developed compounds, compositions, and methods for utilizing E-selectin antagonists. His work provides innovative approaches to treating diseases where inhibiting the binding of E-selectin to an E-selectin ligand is beneficial. The patents include inventions of glycomimetic compounds, antibodies, aptamers, and peptides tailored for cancer treatment. Additionally, he has introduced galactopyranosyl-cyclohexyl derivatives that serve as E-selectin antagonists, providing new pharmaceutical compositions aimed at treating and preventing various health conditions by obstructing E-selectin binding.

Career Highlights

Sarkar's career is marked by significant advancements in therapeutic strategies aimed at oncology. His tenure at Glycomimetics, Inc. highlights his dedication to pioneering drug development, particularly in the realm of glycomimetics. His research has led to critical insights that have the potential to transform cancer treatment and improve patient outcomes.

Collaborations

Throughout his career, Sarkar has collaborated with notable coworkers such as John L Magnani and Myung-Gi Baek. These partnerships have been instrumental in furthering research and advancing the understanding of E-selectin's role in disease pathology. Collaboration among these experts enhances the innovation process and fosters a multidisciplinary approach to solving complex medical challenges.

Conclusion

Arun K Sarkar's contributions to the pharmaceutical field through his extensive patent portfolio underscore his role as an inventor at the forefront of medical innovation. His work in developing E-selectin antagonists exemplifies how targeted therapies can lead to significant improvements in treating various diseases, particularly cancers. Sarkar's dedication to research and collaboration continues to inspire advancements in healthcare and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…